Dabigatran versus Warfarin Therapy for Uninterrupted Oral Anticoagulation During Atrial Fibrillation Ablation

Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin

(2012) Sai V. Konduru et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation

(2012) Dhanunjaya Lakkireddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Use of Dabigatran Immediately After Atrial Fibrillation Ablation

(2011) ROGER A. WINKLE et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

New Anticoagulants for Prevention of Stroke in Patients with Atrial Fibrillation

(2011) JUAN F. VILES-GONZALEZ et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)

(2011) L. Samuel Wann et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Periprocedural Stroke and Management of Major Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation

(2010) Luigi Di Biase et al.   CIRCULATION

Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity

(2010) Joachim Stangier et al.   THROMBOSIS AND HAEMOSTASIS

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage

(2008) Stephan A. Mayer et al.   NEW ENGLAND JOURNAL OF MEDICINE